Q Line Biotech Ltd vs Skyline Ventures India Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Nov 01, 2026

Key Highlights

The Latest Trading Price of Q-Line Biotech Ltd is ₹ 512.75 as of 30 Oct 15:30 . The P/E Ratio of Q-Line Biotech Ltd changed from 0 on March 2023 to 0 on March 2026 . This represents a CAGR of 0.0% over 4 yearsThe P/E Ratio of Skyline Ventures India Ltd changed from 0 on March 2023 to 0 on March 2026 . This represents a CAGR of 0.0% over 4 years The Market Cap of Q-Line Biotech Ltd changed from ₹ 0 crore on March 2023 to ₹ 0 crore on March 2026 . This represents a CAGR of 0.0% over 4 yearsThe Market Cap of Skyline Ventures India Ltd changed from ₹ 0 crore on March 2023 to ₹ 0 crore on March 2026 . This represents a CAGR of 0.0% over 4 years The Revenue of Q-Line Biotech Ltd is ₹ 90.03 crore as of Dec '25 .The Revenue of Skyline Ventures India Ltd is ₹ 0 crore as of Dec '25 . The EBITDA of Q-Line Biotech Ltd is ₹ 30.54 crore as of Dec '25 .The EBITDA of Skyline Ventures India Ltd is ₹ 0 crore as of Dec '25 . The Net Profit of Q-Line Biotech Ltd is ₹ 17.38 crore as of Dec '25 .The Net Profit of Skyline Ventures India Ltd is ₹ 0 crore as of Dec '25 . The Dividend Payout of Q-Line Biotech Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Skyline Ventures India Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Q-Line Biotech Ltd

Q-Line Biotech Limited was originally incorporated as 'POCT Services Private Limited' on November 10, 2010 as a Private limited company dated November 10, 2010 issued by the Assistant Registrar of Companies, Uttar Pradesh and Uttarakhand.
Subsequently, the name of Company was changed to 'Q-Line Biotech Private Limited on July 23, 2021.
Further, Company was converted from a private company to public company and the name of Company was changed to 'Q-Line Biotech Limited', via fresh certificate of incorporation dated March 08, 2025 issued by Central Processing Centre. The Company is engaged in the business of developing, manufacturing and marketing of diverse range of reagents (including kits and POC devices) & consumables and manufacturing, importing, distribution/supply of diagnostic equipment for different diagnostic healthcare needs.

About Skyline Ventures India Ltd

Skyline Ventures India Limited was initially incorporated as Vishwakarma Securities Limited on November 17, 1988.
Name of the Company was changed from Vishwakarma Securities Limited to Paramatma Enterprises Limited on December 27, 2005 and further was renamed as Skyline Ventures India Limited on November 11, 2010.
The Company started operations as an investment Company in Andhra Pradesh.
The Company diversified the business operations in 2005 into the infrastructure, power and other sectors and is presently engaged into the business of Construction and Trading. The Company has a well diversified business portfolio spread across ten business verticals viz., Buildings & Housing, Roads, Water & Environment, Electrical, Irrigation, Metals, Power, International, Mining and Railways.
It executed complex engineering projects across the country.

FAQs for the comparison of Q-Line Biotech Ltd and Skyline Ventures India Ltd

Which company has a larger market capitalization, Q-Line Biotech Ltd or Skyline Ventures India Ltd?

Market cap of Q-Line Biotech Ltd is 1,196 Cr while Market cap of Skyline Ventures India Ltd is 7 Cr

What are the key factors driving the stock performance of Q-Line Biotech Ltd and Skyline Ventures India Ltd?

The stock performance of Q-Line Biotech Ltd and Skyline Ventures India Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Q-Line Biotech Ltd and Skyline Ventures India Ltd?

As of November 1, 2026, the Q-Line Biotech Ltd stock price is INR ₹512.75. On the other hand, Skyline Ventures India Ltd stock price is INR ₹19.0.

How do dividend payouts of Q-Line Biotech Ltd and Skyline Ventures India Ltd compare?

To compare the dividend payouts of Q-Line Biotech Ltd and Skyline Ventures India Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.